Ovulation Inducing Drugs Market

The global ovulation inducing drugs market size was valued at USD 4.82 billion in 2025and is expected to reach USD 7.68 billion by 2033, at a CAGR of 6.00% during the forecast period The market growth is largely fueled by the rising prevalence of infertility cases, delayed pregnancies, and hormonal disorders such as polycystic ovary syndrome (PCOS), which are increasing the demand for ovulation-stimulating therapies across fertility clinics and healthcare systems Furthermore, growing awareness regarding assisted reproductive technologies (ART), improved access to fertility treatments, and expanding healthcare infrastructure in emerging economies are driving adoption of ovulation inducing drugs, thereby significantly boosting the industry's growth https://www.databridgemarketresearch.com/reports/global-ovulation-inducing-drugs-market